2024 Breakthrough Prize honors medical innovations transforming lives
Breakthrough Prize Foundation - 14-Sep-2023Game-changing treatments for cancer, cystic fibrosis, and parkinson’s
Join the club for FREE to access the whole archive and other member benefits.
Chief of the Molecular Neurogenetics Section at National Human Genome Research Institute
Dr. Ellen Sidransky is chief of the Molecular Neurogenetics Section at the National Human Genome Research Institute, NIH. A pediatrician and clinical geneticist, she is renowned for her research on Gaucher disease and Parkinson's disease, notably identifying glucocerebrosidase as a risk factor for parkinsonism. Dr. Sidransky has led large international studies on Parkinson’s and dementia with Lewy bodies and currently focuses on the genetic complexity of Mendelian disorders and developing therapies for Gaucher disease. She has authored over 200 papers and received multiple awards, including the NIH Director’s Award.
Visit website: https://irp.nih.gov/pi/ellen-sidransky
See also: National Human Genome Research Institute (NHGRI) - Institute of the National Institutes of Health.
Details last updated 24-Sep-2024
Game-changing treatments for cancer, cystic fibrosis, and parkinson’s